CVS Health (CVS): Cutting Estimates On Pricing Concerns - Leerink
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Leerink Partners analyst, David Larsen, reiterated his Outperform rating on shares of CVS Health (NYSE: CVS) but cut his price target to $105.00 from $110.00 on pricing concerns. The analyst recently spoke with a MEDACorp specialist who has decades of experience with PBM and Managed Care contracting, believes that pricing has slowed materially over the past 9 months.
As a result he reduced 2H:16 and 2017 revenue and EPS estimates for CVS Health. This information makes him incrementally more cautious on the PBMs, Distributors and Retailers,
Shares of CVS Health closed at $89.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Raises Price Target on Microsoft (MSFT) to $65 Following 1Q Beat
- KLR Group Raises Price Target on SM Energy (SM) to $59; Reiterates Buy
- Jefferies Raises Price Target on FMC Technologies (FTI) After Adjusting Estimates
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change, Hot List
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!